1 Introduction to Research & Analysis Reports 1.1 Dendritic Cell Cancer Vaccine Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Dendritic Cell Cancer Vaccine Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Dendritic Cell Cancer Vaccine Overall Market Size 2.1 China Dendritic Cell Cancer Vaccine Market Size: 2021 VS 2027 2.2 China Dendritic Cell Cancer Vaccine Revenue, Prospects & Forecasts: 2016-2027 2.3 China Dendritic Cell Cancer Vaccine Sales: 2016-2027 3 Company Landscape 3.1 Top Dendritic Cell Cancer Vaccine Players in China Market 3.2 Top China Dendritic Cell Cancer Vaccine Companies Ranked by Revenue 3.3 China Dendritic Cell Cancer Vaccine Revenue by Companies 3.4 China Dendritic Cell Cancer Vaccine Sales by Companies 3.5 China Dendritic Cell Cancer Vaccine Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Dendritic Cell Cancer Vaccine Companies in China Market, by Revenue in 2020 3.7 Manufacturers Dendritic Cell Cancer Vaccine Product Type 3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Players in China Market 3.8.1 List of Tier 1 Dendritic Cell Cancer Vaccine Companies in China 3.8.2 List of Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Dendritic Cell Cancer Vaccine Market Size Markets, 2021 & 2027 4.1.2 CreaVax 4.1.3 Sipuleucel-T (Provenge) 4.1.4 Others 4.2 By Type - China Dendritic Cell Cancer Vaccine Revenue & Forecasts 4.2.1 By Type - China Dendritic Cell Cancer Vaccine Revenue, 2016-2021 4.2.2 By Type - China Dendritic Cell Cancer Vaccine Revenue, 2022-2027 4.2.3 By Type - China Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027 4.3 By Type - China Dendritic Cell Cancer Vaccine Sales & Forecasts 4.3.1 By Type - China Dendritic Cell Cancer Vaccine Sales, 2016-2021 4.3.2 By Type - China Dendritic Cell Cancer Vaccine Sales, 2022-2027 4.3.3 By Type - China Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027 4.4 By Type - China Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Dendritic Cell Cancer Vaccine Market Size, 2021 & 2027 5.1.2 Pediatrics 5.1.3 Adults 5.2 By Application - China Dendritic Cell Cancer Vaccine Revenue & Forecasts 5.2.1 By Application - China Dendritic Cell Cancer Vaccine Revenue, 2016-2021 5.2.2 By Application - China Dendritic Cell Cancer Vaccine Revenue, 2022-2027 5.2.3 By Application - China Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027 5.3 By Application - China Dendritic Cell Cancer Vaccine Sales & Forecasts 5.3.1 By Application - China Dendritic Cell Cancer Vaccine Sales, 2016-2021 5.3.2 By Application - China Dendritic Cell Cancer Vaccine Sales, 2022-2027 5.3.3 By Application - China Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027 5.4 By Application - China Dendritic Cell Cancer Vaccine Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Activarti 6.1.1 Activarti Corporation Information 6.1.2 Activarti Overview 6.1.3 Activarti Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.1.4 Activarti Dendritic Cell Cancer Vaccine Product Description 6.1.5 Activarti Recent Developments 6.2 Argos Therapeutics 6.2.1 Argos Therapeutics Corporation Information 6.2.2 Argos Therapeutics Overview 6.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Product Description 6.2.5 Argos Therapeutics Recent Developments 6.3 SOTIO (Acquired by PPF Group) 6.3.1 SOTIO (Acquired by PPF Group) Corporation Information 6.3.2 SOTIO (Acquired by PPF Group) Overview 6.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Description 6.3.5 SOTIO (Acquired by PPF Group) Recent Developments 6.4 Bellicum Pharmaceuticals 6.4.1 Bellicum Pharmaceuticals Corporation Information 6.4.2 Bellicum Pharmaceuticals Overview 6.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Description 6.4.5 Bellicum Pharmaceuticals Recent Developments 6.5 JW CreaGene 6.5.1 JW CreaGene Corporation Information 6.5.2 JW CreaGene Overview 6.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Product Description 6.5.5 JW CreaGene Recent Developments 6.6 DanDrit 6.6.1 DanDrit Corporation Information 6.6.2 DanDrit Overview 6.6.3 DanDrit Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.6.4 DanDrit Dendritic Cell Cancer Vaccine Product Description 6.6.5 DanDrit Recent Developments 6.7 DCPrime 6.7.1 DCPrime Corporation Information 6.7.2 DCPrime Overview 6.7.3 DCPrime Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.7.4 DCPrime Dendritic Cell Cancer Vaccine Product Description 6.7.5 DCPrime Recent Developments 6.8 Elios Therapeutics 6.8.1 Elios Therapeutics Corporation Information 6.8.2 Elios Therapeutics Overview 6.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Product Description 6.8.5 Elios Therapeutics Recent Developments 6.9 ImmunoCellular Therapeutics 6.9.1 ImmunoCellular Therapeutics Corporation Information 6.9.2 ImmunoCellular Therapeutics Overview 6.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Description 6.9.5 ImmunoCellular Therapeutics Recent Developments 6.10 Kiromic 6.10.1 Kiromic Corporation Information 6.10.2 Kiromic Overview 6.10.3 Kiromic Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.10.4 Kiromic Dendritic Cell Cancer Vaccine Product Description 6.10.5 Kiromic Recent Developments 6.11 Medigene 6.11.1 Medigene Corporation Information 6.11.2 Medigene Overview 6.11.3 Medigene Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.11.4 Medigene Dendritic Cell Cancer Vaccine Product Description 6.11.5 Medigene Recent Developments 6.12 Merck 6.12.1 Merck Corporation Information 6.12.2 Merck Overview 6.12.3 Merck Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.12.4 Merck Dendritic Cell Cancer Vaccine Product Description 6.12.5 Merck Recent Developments 6.13 Northwest Biotherapeutics 6.13.1 Northwest Biotherapeutics Corporation Information 6.13.2 Northwest Biotherapeutics Overview 6.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.13.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Description 6.13.5 Northwest Biotherapeutics Recent Developments 6.14 Immutep Limited 6.14.1 Immutep Limited Corporation Information 6.14.2 Immutep Limited Overview 6.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.14.4 Immutep Limited Dendritic Cell Cancer Vaccine Product Description 6.14.5 Immutep Limited Recent Developments 6.15 Dendreon Corporation 6.15.1 Dendreon Corporation Corporation Information 6.15.2 Dendreon Corporation Overview 6.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.15.4 Dendreon Corporation Dendritic Cell Cancer Vaccine Product Description 6.15.5 Dendreon Corporation Recent Developments 6.16 Oncobiomed 6.16.1 Oncobiomed Corporation Information 6.16.2 Oncobiomed Overview 6.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Sales and Revenue in China Market (2016-2021) 6.16.4 Oncobiomed Dendritic Cell Cancer Vaccine Product Description 6.16.5 Oncobiomed Recent Developments 7 China Dendritic Cell Cancer Vaccine Production Capacity, Analysis 7.1 China Dendritic Cell Cancer Vaccine Production Capacity, 2016-2027 7.2 Dendritic Cell Cancer Vaccine Production Capacity of Key Manufacturers in China Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Dendritic Cell Cancer Vaccine Supply Chain Analysis 9.1 Dendritic Cell Cancer Vaccine Industry Value Chain 9.2 Dendritic Cell Cancer Vaccine Upstream Market 9.3 Dendritic Cell Cancer Vaccine Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Dendritic Cell Cancer Vaccine Distributors and Sales Agents in China Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Dendritic Cell Cancer Vaccine in China Market Table 2. Top Dendritic Cell Cancer Vaccine Players in China Market, Ranking by Revenue (2019) Table 3. China Dendritic Cell Cancer Vaccine Revenue by Companies, (US$, Mn), 2016-2021 Table 4. China Dendritic Cell Cancer Vaccine Revenue Share by Companies, 2016-2021 Table 5. China Dendritic Cell Cancer Vaccine Sales by Companies, (K Doses), 2016-2021 Table 6. China Dendritic Cell Cancer Vaccine Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Dendritic Cell Cancer Vaccine Price (2016-2021) & (USD/Dose) Table 8. Manufacturers Dendritic Cell Cancer Vaccine Product Type Table 9. List of Tier 1 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Dendritic Cell Cancer Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of CreaVax Table 12. Major Manufacturers of Sipuleucel-T (Provenge) Table 13. By Type – China Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - China Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2016-2021 Table 15. By Type - China Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2022-2027 Table 16. By Type - China Dendritic Cell Cancer Vaccine Sales (K Doses), 2016-2021 Table 17. By Type - China Dendritic Cell Cancer Vaccine Sales (K Doses), 2022-2027 Table 18. By Application – China Dendritic Cell Cancer Vaccine Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - China Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2016-2021 Table 20. By Application - China Dendritic Cell Cancer Vaccine Revenue (US$, Mn), 2022-2027 Table 21. By Application - China Dendritic Cell Cancer Vaccine Sales (K Doses), 2016-2021 Table 22. By Application - China Dendritic Cell Cancer Vaccine Sales (K Doses), 2022-2027 Table 23. Activarti Corporation Information Table 24. Activarti Description and Major Businesses Table 25. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 26. Activarti Dendritic Cell Cancer Vaccine Product Table 27. Activarti Recent Developments Table 28. Argos Therapeutics Corporation Information Table 29. Argos Therapeutics Description and Major Businesses Table 30. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 31. Argos Therapeutics Dendritic Cell Cancer Vaccine Product Table 32. Argos Therapeutics Recent Developments Table 33. SOTIO (Acquired by PPF Group) Corporation Information Table 34. SOTIO (Acquired by PPF Group) Description and Major Businesses Table 35. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 36. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Table 37. SOTIO (Acquired by PPF Group) Recent Developments Table 38. Bellicum Pharmaceuticals Corporation Information Table 39. Bellicum Pharmaceuticals Description and Major Businesses Table 40. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 41. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Table 42. Bellicum Pharmaceuticals Recent Developments Table 43. JW CreaGene Corporation Information Table 44. JW CreaGene Description and Major Businesses Table 45. JW CreaGene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 46. JW CreaGene Dendritic Cell Cancer Vaccine Product Table 47. JW CreaGene Recent Developments Table 48. DanDrit Corporation Information Table 49. DanDrit Description and Major Businesses Table 50. DanDrit Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 51. DanDrit Dendritic Cell Cancer Vaccine Product Table 52. DanDrit Recent Developments Table 53. DCPrime Corporation Information Table 54. DCPrime Description and Major Businesses Table 55. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 56. DCPrime Dendritic Cell Cancer Vaccine Product Table 57. DCPrime Recent Developments Table 58. Elios Therapeutics Corporation Information Table 59. Elios Therapeutics Description and Major Businesses Table 60. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 61. Elios Therapeutics Dendritic Cell Cancer Vaccine Product Table 62. Elios Therapeutics Recent Developments Table 63. ImmunoCellular Therapeutics Corporation Information Table 64. ImmunoCellular Therapeutics Description and Major Businesses Table 65. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 66. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Table 67. ImmunoCellular Therapeutics Recent Developments Table 68. Kiromic Corporation Information Table 69. Kiromic Description and Major Businesses Table 70. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 71. Kiromic Dendritic Cell Cancer Vaccine Product Table 72. Kiromic Recent Developments Table 73. Medigene Corporation Information Table 74. Medigene Description and Major Businesses Table 75. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 76. Medigene Dendritic Cell Cancer Vaccine Product Table 77. Medigene Recent Developments Table 78. Merck Corporation Information Table 79. Merck Description and Major Businesses Table 80. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 81. Merck Dendritic Cell Cancer Vaccine Product Table 82. Merck Recent Developments Table 83. Northwest Biotherapeutics Corporation Information Table 84. Northwest Biotherapeutics Description and Major Businesses Table 85. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 86. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Table 87. Northwest Biotherapeutics Recent Developments Table 88. Immutep Limited Corporation Information Table 89. Immutep Limited Description and Major Businesses Table 90. Immutep Limited Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 91. Immutep Limited Dendritic Cell Cancer Vaccine Product Table 92. Immutep Limited Recent Developments Table 93. Dendreon Corporation Corporation Information Table 94. Dendreon Corporation Description and Major Businesses Table 95. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 96. Dendreon Corporation Dendritic Cell Cancer Vaccine Product Table 97. Dendreon Corporation Recent Developments Table 98. Oncobiomed Corporation Information Table 99. Oncobiomed Description and Major Businesses Table 100. Oncobiomed Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$, Mn) and Gross Margin (USD/Dose) (2016-2021) Table 101. Oncobiomed Dendritic Cell Cancer Vaccine Product Table 102. Oncobiomed Recent Developments Table 103. Dendritic Cell Cancer Vaccine Production Capacity (K Doses) of Key Manufacturers in China Market, 2019-2021 (K Doses) Table 104. China Dendritic Cell Cancer Vaccine Capacity Market Share of Key Manufacturers, 2019-2021 Table 105. Dendritic Cell Cancer Vaccine Market Opportunities & Trends in China Market Table 106. Dendritic Cell Cancer Vaccine Market Drivers in China Market Table 107. Dendritic Cell Cancer Vaccine Market Restraints in China Market Table 108. Dendritic Cell Cancer Vaccine Raw Materials Table 109. Dendritic Cell Cancer Vaccine Raw Materials Suppliers in China Market Table 110. Typical Dendritic Cell Cancer Vaccine Downstream Table 111. Dendritic Cell Cancer Vaccine Downstream Clients in China Market Table 112. Dendritic Cell Cancer Vaccine Distributors and Sales Agents in China Market List of Figures Figure 1. Dendritic Cell Cancer Vaccine Product Picture Figure 2. Dendritic Cell Cancer Vaccine Segment by Type Figure 3. Dendritic Cell Cancer Vaccine Segment by Application Figure 4. China Dendritic Cell Cancer Vaccine Market Overview: 2020 Figure 5. China Dendritic Cell Cancer Vaccine Market Size: 2021 VS 2027 (US$, Mn) Figure 6. China Dendritic Cell Cancer Vaccine Revenue, 2016-2027 (US$, Mn) Figure 7. Dendritic Cell Cancer Vaccine Sales in China Market: 2016-2027 (K Doses) Figure 8. The Top 3 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Revenue in 2020 Figure 9. CreaVax Product Picture Figure 10. Sipuleucel-T (Provenge) Product Picture Figure 11. Others Product Picture Figure 12. By Type - China Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027 Figure 13. By Type - China Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027 Figure 14. By Type - China Dendritic Cell Cancer Vaccine Price (USD/Dose), 2016-2027 Figure 15. Pediatrics Figure 16. Adults Figure 17. By Application - China Dendritic Cell Cancer Vaccine Sales Market Share, 2016-2027 Figure 18. By Application - China Dendritic Cell Cancer Vaccine Revenue Market Share, 2016-2027 Figure 19. By Application - China Dendritic Cell Cancer Vaccine Price (USD/Dose), 2016-2027 Figure 20. Activarti Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Argos Therapeutics Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. JW CreaGene Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. DanDrit Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. DCPrime Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Elios Therapeutics Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. Kiromic Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. Medigene Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 31. Merck Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 32. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 33. Immutep Limited Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 34. Dendreon Corporation Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 35. Oncobiomed Dendritic Cell Cancer Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 36. China Dendritic Cell Cancer Vaccine Production Capacity (K Doses), 2016-2027 Figure 37. Dendritic Cell Cancer Vaccine Industry Value Chain Figure 38. Marketing Channels

Activarti Argos Therapeutics SOTIO (Acquired by PPF Group) Bellicum Pharmaceuticals JW CreaGene DanDrit DCPrime Elios Therapeutics ImmunoCellular Therapeutics Kiromic Medigene Merck Northwest Biotherapeutics Immutep Limited Dendreon Corporation Oncobiomed